Efficacy and Safety of Budesonide Inhalation Suspension for the Treatment of Chronic Rhinosinusitis With Polyposis.
Launched by BEIJING TONGREN HOSPITAL · Sep 25, 2018
Trial Information
Current as of May 20, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosis of chronic rhinosinusitis was made on the basis of symptoms of rhinosinusitis (nasal obstruction, rhinorhea, loss of smell, and headache/facial pain) for at least 12 weeks, confirmed by abnormalities in all sinuses on computed tomography (CT) scan. The diagnosis of CRSwNP was based on the standard criteria issued in the European Position Paper on Rhinosinusitis and Nasal Polyps guidelines.
- • Bilateral nasal polyps were present and endoscopic biopsy demonstrated eosinophilic polyposis. Patients were not recruited who had large polyps (total Kennedy score＝6).
- Exclusion Criteria:
- • a previous oral corticosteroid treatment.
- • recent sinus surgery
- • ASA intolerance
- • cystic fibrosis
- • pregnancy
- • serious or unstable concurrent disease or psychological disorder.
About Beijing Tongren Hospital
Beijing Tongren Hospital, affiliated with Capital Medical University, is a leading medical institution in China known for its comprehensive clinical services and research initiatives. With a strong focus on ophthalmology and a commitment to advancing healthcare through innovative clinical trials, the hospital leverages its expertise in various specialties to contribute to medical knowledge and improve patient outcomes. The institution is dedicated to adhering to the highest ethical standards and regulatory requirements, ensuring the integrity and reliability of its research endeavors. Through collaboration with national and international partners, Beijing Tongren Hospital aims to enhance the quality of care and foster advancements in medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials